Stocks

Amylyx Pharmaceuticals AMLX

Health care sectorNasdaq

What to see in Amylyx Pharmaceuticals now

Is Wall Street adding or cutting?+36

207 13F filers hold it · +36 against the quarter before · shares held +0.6%

Holdings of 06/30
Is stock about to come to market?$2.9M

$2.9M of planned sales filed in 30 days · 14.9% of the units outstanding

Filed 09/11

Company

Exchange
Nasdaq
Industry
Pharmaceutical Preparations
Headquarters
Cambridge, Massachusetts
Fiscal year end
12/31
Next earnings
11/05, estimated
  • 207 13F filers hold it · +36 against the quarter before · shares held +0.6%Holdings of 06/30

Funds

13F filers: 207 · +36 since the quarter before · 06/30 holdings

Famous funds that held Amylyx Pharmaceuticals in their latest 13F report.

FundValueSince the quarter before
Mirae Asset Global ETFS HoldingsAmylyx Pharmaceuticals AMLX · 06/30 holdings$760.6KNo quarter before
Mirae Asset Global InvestmentsAmylyx Pharmaceuticals AMLX · 06/30 holdings$89.3KTrimmed −13.2%
All tracked funds

5% stakes

Holder
Vanguard Group03/260%0 sh−5.3pp
Adage Capital Management02/122.53%2,777,055 sh−3.9pp
FMR02/0515%16,468,419 sh+4.3pp
Vanguard Group01/305.28%5,804,912 sh+0.3pp
BlackRock01/217.1%7,783,648 sh+1.6pp
Commodore Capital25/11/175.1%5,650,000 shFirst report
Point72 Asset Management25/11/142.6%2,801,636 sh−2.7pp
Adage Capital Management25/11/136.39%6,816,828 sh−3.5pp
Vanguard Group25/10/304.94%5,273,750 sh−0.1pp
FMR25/10/0710.7%11,379,207 shFirst report
Adage Capital Management25/08/129.87%8,800,000 sh+3.4pp
Vanguard Group25/07/295.04%4,498,028 shFirst report
BlackRock25/07/175.5%4,917,501 shFirst report
Point72 Asset Management25/06/255.3%4,717,709 sh+4.1pp
Point72 Asset Management25/05/151.2%1,048,343 sh−4.4pp
Adage Capital Management25/05/126.43%5,697,605 shFirst report
Point72 Asset Management25/01/145.6%4,820,333 shFirst report
All 5% stake reports on Amylyx Pharmaceuticals

26-week trading